Published in Neuropsychopharmacology on August 01, 1998
Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond. Biol Psychiatry (2013) 1.92
Are anticorrelated networks in the brain relevant to schizophrenia? Schizophr Bull (2007) 1.65
Animal models of schizophrenia. Br J Pharmacol (2011) 1.60
Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev (2008) 1.46
Modulators in concert for cognition: modulator interactions in the prefrontal cortex. Prog Neurobiol (2007) 1.28
Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia. Neuropsychopharmacology (2009) 1.20
The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment. Psychopharmacology (Berl) (2011) 1.09
Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex. Psychopharmacology (Berl) (2005) 1.07
Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats. Psychopharmacology (Berl) (2008) 1.01
Repeated phencyclidine in monkeys results in loss of parvalbumin-containing axo-axonic projections in the prefrontal cortex. Psychopharmacology (Berl) (2007) 1.01
Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins. Psychopharmacology (Berl) (2012) 0.97
Effects of Subchronic Phencyclidine (PCP) Treatment on Social Behaviors, and Operant Discrimination and Reversal Learning in C57BL/6J Mice. Front Behav Neurosci (2009) 0.97
Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia. Eur Neuropsychopharmacol (2013) 0.92
GABAB/NMDA receptor interaction in the regulation of extracellular dopamine levels in rodent prefrontal cortex and striatum. Neuropharmacology (2009) 0.90
Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptors. Br J Pharmacol (2002) 0.87
Analysis of licking microstructure provides no evidence for a reduction in reward value following acute or sub-chronic phencyclidine administration. Psychopharmacology (Berl) (2010) 0.86
Superstitious conditioning as a model of delusion formation following chronic but not acute ketamine in humans. Psychopharmacology (Berl) (2009) 0.86
Sensitization to amphetamine, but not phencyclidine, disrupts prepulse inhibition and latent inhibition. Psychopharmacology (Berl) (2005) 0.86
Neuropathological changes in the substantia nigra in schizophrenia but not depression. Eur Arch Psychiatry Clin Neurosci (2013) 0.85
Adult response to olanzapine or clozapine treatment is altered by adolescent antipsychotic exposure: a preclinical test in the phencyclidine hyperlocomotion model. J Psychopharmacol (2013) 0.84
Subchronic elevation of brain kynurenic acid augments amphetamine-induced locomotor response in mice. J Neural Transm (Vienna) (2011) 0.84
Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model. Neuropsychopharmacology (2015) 0.82
The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment. Curr Neuropharmacol (2014) 0.82
Neonatal phencyclidine administration and post-weaning social isolation as a dual-hit model of 'schizophrenia-like' behaviour in the rat. Psychopharmacology (Berl) (2014) 0.77
No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia. J Clin Psychopharmacol (2013) 0.76
Disruption of medial prefrontal synchrony in the subchronic phencyclidine model of schizophrenia in rats. Neuroscience (2014) 0.76
Ethanol and phencyclidine interact with respect to nucleus accumbens dopamine release: differential effects of administration order and pretreatment protocol. Front Behav Neurosci (2010) 0.76
The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia. Psychopharmacology (Berl) (2015) 0.75
A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates. Curr Neuropharmacol (2015) 0.75
Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) (1999) 7.06
Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol (1989) 4.96
The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology (1999) 3.78
A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut (2008) 3.47
Contribution of fish to the marine inorganic carbon cycle. Science (2009) 3.17
Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature (2001) 3.09
Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci (1997) 2.43
Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med (1992) 2.39
Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci (1999) 2.36
Severe necrotizing cutaneous lesions complicating treatment with interferon beta-1b. N Engl J Med (1995) 2.32
Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience (2003) 2.19
Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmacol (1971) 2.17
Accuracy of statistical methods in TRANSFUSION: a review of articles from July/August 1992 through June 1993. Transfusion (1994) 2.15
Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol (1990) 2.10
Optophysiology: depth-resolved probing of retinal physiology with functional ultrahigh-resolution optical coherence tomography. Proc Natl Acad Sci U S A (2006) 2.05
Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther (1973) 2.05
Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science (1997) 2.01
Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol (1989) 2.01
Enhanced behavioural control by conditioned reinforcers following microinjections of d-amphetamine into the nucleus accumbens. Psychopharmacology (Berl) (1984) 1.89
Psychosocial impact of urinary incontinence in women. Obstet Gynecol (1987) 1.89
Growth of human intervertebral discs and vertebral bodies. J Anat (1975) 1.85
Low-back pain associated with leg length inequality. Spine (Phila Pa 1976) (1982) 1.79
Efficacy of bladder training in older women with urinary incontinence. JAMA (1991) 1.77
False-negative cytology rates in patients in whom invasive cervical cancer subsequently developed. Obstet Gynecol (1982) 1.75
Limbic-striatal interactions in reward-related processes. Neurosci Biobehav Rev (1989) 1.74
Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors. Oncogene (2008) 1.73
Toward a neurobiology of delusions. Prog Neurobiol (2010) 1.70
Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci U S A (1996) 1.66
Acceleration of noradrenaline biosynthesis in the guinea-pig vas deferens by potassium. Br J Pharmacol (1970) 1.64
Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol (2001) 1.63
Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat New Biol (1973) 1.61
Selective reduction of tryptophan hydroxylase activity in rat forebrain after midbrain raphe lesions. Brain Res (1971) 1.54
Unsuspected damage to lumbar zygapophyseal (facet) joints after motor-vehicle accidents. Med J Aust (1989) 1.52
Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol (2001) 1.49
The prepuce. BJU Int (1999) 1.48
Comparison of effects of transforming growth factor-beta and cyclosporin A on antigen-presenting cells of blood and epidermis. J Invest Dermatol (1991) 1.48
Leucocyte counts on blood donors in Nairobi. East Afr Med J (1969) 1.47
Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function. Biol Psychiatry (1999) 1.46
The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog Brain Res (1990) 1.45
Choline: selective accumulation by central cholinergic neurons. J Neurochem (1973) 1.45
Cerebral infarction in young adults. Stroke (1978) 1.45
Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease. Exp Neurol (1997) 1.43
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Susceptibility to a parkinsonian toxin varies during primate development. Exp Neurol (2012) 1.41
Fetal neural graft survival. Lancet (1990) 1.40
A role for norepinephrine in stress-induced cognitive deficits: alpha-1-adrenoceptor mediation in the prefrontal cortex. Biol Psychiatry (1999) 1.39
Comment on Roth appliance. Am J Orthod Dentofacial Orthop (1993) 1.39
Spontaneous blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys. Exp Neurol (1999) 1.38
Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci (1996) 1.38
6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine. Psychopharmacology (Berl) (1986) 1.37
Presence of acetylcholine and transmitter release from carotid body chemoreceptors. J Physiol (1965) 1.32
Variations in noradrenaline output with respect to stimulus frequency, train length and origin of the transmitter. Br J Pharmacol (1972) 1.32
Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J Neurosci (2000) 1.30
Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J Neurosci (1997) 1.28
Pharmacology of mesocortical dopamine neurons. Pharmacol Rev (1983) 1.27
Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology (1997) 1.25
Mechanism of the gamma-hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep". Biochem Pharmacol (1970) 1.24
Acceleration of noradrenaline biosynthesis by nerve stimulation. Life Sci (1966) 1.23
Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience (1984) 1.22
The Reversion Of L Type Cultures Previously Described As Pleuropneumonialike and Associated with Chronic Respiratory Disease-To An Organism Resembling Gallinarum. Can J Comp Med Vet Sci (1954) 1.22
Dialytrode for long term intracerebral perfusion in awake monkeys. Arch Int Pharmacodyn Ther (1972) 1.21
Variation in noradrenaline output with changes in stimulus frequency and train length: role of different noradrenaline pools. Br J Pharmacol (1974) 1.19
The action of reserpine on noradrenaline biosynthesis in sympathetic nerve tissue. Biochem Pharmacol (1968) 1.16
In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther (1998) 1.16
Spirometric tests to diagnose suspected asthma. Am Rev Respir Dis (1969) 1.15
Potentiation of the effects of reward-related stimuli by dopaminergic-dependent mechanisms in the nucleus accumbens. Psychopharmacology (Berl) (1991) 1.14
Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice. J Virol (2000) 1.14
Nicotine receptor inactivation decreases sensitivity to cocaine. Neuropsychopharmacology (2001) 1.13
The role of mesoprefrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience (1999) 1.13
Telencephalic projections of the A8 dopamine cell group. Ann N Y Acad Sci (1988) 1.13
Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol (2000) 1.12
Autoreceptor regulation of dopamine synthesis. Ann N Y Acad Sci (1990) 1.12
Amitriptyline plasma levels and therapeutic response. Clin Pharmacol Ther (1976) 1.11
Effects of ultraviolet B light on cutaneous immune responses of humans with deeply pigmented skin. J Invest Dermatol (1991) 1.11
Patients with MCI and N400 or P600 abnormalities are at very high risk for conversion to dementia. Neurology (2007) 1.11
Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats. Neuropsychopharmacology (2001) 1.10
Persistence of the notochordal canal in vertebrae. J Anat (1972) 1.10
Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci (1991) 1.10
The predator odor, TMT, displays a unique, stress-like pattern of dopaminergic and endocrinological activation in the rat. Brain Res (2000) 1.09
Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment. J Neurosci (1996) 1.09
Functional occlusion for the orthodontist. J Clin Orthod (1981) 1.09
Sexual dimorphism in human vertebral body shape. J Anat (1984) 1.08
Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res (1990) 1.07
Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action. Prog Brain Res (2000) 1.07
Age changes in lumbar vertebrae and intervertebral discs. Clin Orthop Relat Res (1987) 1.06
Gamma-hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy. J Pharmacol Exp Ther (1970) 1.06
Age changes in lumbar zygapophyseal joints. Observations on structure and function. Spine (Phila Pa 1976) (1986) 1.06
Content and release of amino-acids and catecholamines in monkey brain. Nature (1969) 1.06
Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet (1986) 1.06
Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment. Neuroscience (2000) 1.05
Ontogeny of thermoregulation and energy metabolism in pygoscelid penguin chicks. J Comp Physiol B (1985) 1.05
Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neurosci Lett (1989) 1.05
Evidence that central nervous system depression by 1,4-butanediol in mediated through a metabolite, gamma-hydroxybutyrate. Biochem Pharmacol (1968) 1.04
The straight-wire appliance 17 years later. J Clin Orthod (1987) 1.04